DCF Advises on the Sale of ITS Pharmacy, Inc. to Specialty Therapeutic Care Holdings, Inc.
Deloitte Corporate Finance LLC
Deloitte Corporate Finance LLC (DCF) is pleased to announce its role as the exclusive financial advisor to ITS Pharmacy, Inc. (ITSRx).
Specialty Therapeutic Care Holdings, Inc. (STC), a portfolio company of Enhanced Equity Fund, L.P., has acquired ITSRx, a specialty pharmacy focused on providing medications to those suffering from chronic illnesses.
The DCF team assisted ITSRx throughout the process including letter of intent and deal negotiations and the organization of the due diligence process. This transaction further highlights DCF’s experience and focus in the healthcare industry.
About Specialty Therapeutic Care
STC provides healthcare services to meet the specialized needs of individuals with chronic or life threatening disorders. It offers treatment for bleeding disorders, including pharmacy, education, reimbursement and patient advocacy services; immune disorders treatment services; and pulmonary disorders treatment services. STC was founded in 2006 and is based in Houston, Texas.
ITSRx specializes in providing quality specialty medications to those suffering from chronic illnesses such as Hepatitis C, Cancer, Rheumatoid Arthritis, RSV, Cystic Fibrosis, Multiple Sclerosis, and other debilitating diseases. ITSRx is committed to helping such patients manage their complex, high-cost healthcare needs.